KDA Group

KDA Group Diluted EPS

The Diluted Earnings per Share of KDA Group (KDA.V) as of Oct 26, 2026 is -0.05 CAD. In the previous year, Diluted Earnings per Share was -0.04 CAD — a change of 16.52% (lower).

Diluted EPS

-0.05CAD

YoY

16.52%

Last updated:

Diluted Earnings per Share of KDA Group is 2025 -0.05 CAD. Diluted Earnings per Share of KDA Group was 2024 -0.04 CAD. It decreases by 16.52% lower compared to the previous year.

The KDA Group Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2018
-0.12 CAD
Jan 1, 2019
-0.07 CAD
Jan 1, 2020
-0.04 CAD
Jan 1, 2021
0.00 CAD
Jan 1, 2022
-0.03 CAD
Jan 1, 2023
0.10 CAD
Jan 1, 2024
-0.04 CAD
Jan 1, 2025
-0.05 CAD
The KDA Group Diluted EPS history
YEARDiluted EPSYoY
-0.05CAD+16.52%
-0.04CAD-139.04%
0.10CAD-427.58%
-0.03CAD-912.52%
0.00CAD-110.41%
-0.04CAD-51.09%
-0.07CAD-38.76%
-0.12CAD-54.29%
-0.27CAD+2,160.60%
-0.01CAD+14.46%
-0.01CAD-287.16%
0.01CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

KDA Group Stock analysis

What does KDA Group do? KDA Group, Inc. generates revenue through its Pharmacy Services, Pharmaceutical Solutions, and Pharmaceutical Technology segments. The Pharmacy Services segment provides training, consulting, and replacement services for healthcare professionals. The Pharmaceutical Solutions segment develops and integrates technological platforms for healthcare professionals. The Pharmaceutical Technology segment offers KRX, KRX DENTAL, and ADRX platforms, while ZRx Digital Prescriber is an electronic prescriber software for authorized healthcare providers. Subsidiaries like Alliance Pharma Operations Inc. and Elitis Pharma Inc. support these services. Clients include healthcare professionals who require training, consulting, and technological solutions. The Pharmacy Services segment targets professional resource needs in healthcare, while Pharmaceutical Solutions and Technology segments serve healthcare professionals with integrated platforms and digital tools. Subsidiaries such as Logistik Pharma Inc. and Groupe Technologique KDA Inc. contribute to the company's service delivery. Pharmaceutical Technology platforms like KRX, KRX DENTAL, and ADRX are sold to healthcare professionals seeking digital solutions. ZRx Digital Prescriber is utilized by authorized prescribers for medication and treatment management. The company's subsidiaries operate within the segments to deliver specialized services, ensuring comprehensive solutions for healthcare providers. KDA Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about KDA Group stock

Diluted Earnings per Share of KDA Group is -0.05 CAD in 2025.

Diluted Earnings per Share of KDA Group changed from -0.04 CAD to -0.05 CAD, representing a 16.52% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share KDA Group since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — KDA Group

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — KDA Group